Walleye Capital
CLB icon

Walleye Capital’s Core Laboratories CLB Stock Holding History

Walleye Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Buy
+8,600
New +$154K ﹤0.01% 3517
2025
Q4 		– Sell
-12,400
Closed -$153K – 4624
2025
Q3 		$153K Buy
12,400
+2,600
+27% +$30.5K ﹤0.01% 3479
2025
Q2 		$113K Buy
+9,800
New +$116K ﹤0.01% 3719
2024
Q4 		– Sell
-2,600
Closed -$48.2K – 4921
2024
Q3 		$48.2K Sell
2,600
-4,800
-65% -$96.4K ﹤0.01% 4651
2024
Q2 		$150K Buy
+7,400
New +$131K ﹤0.01% 4491
2020
Q1 		– Sell
-8,000
Closed -$301K – 1026
2019
Q4 		$301K Sell
8,000
-15,500
-66% -$696K 0.02% 920
2019
Q3 		$1.1M Buy
+23,500
New +$1.09M 0.07% 411

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's CLB Position: Q4 2024 in Review

Walleye Capital sold out of Core Laboratories (CLB) in Q4 2024, closing a stake of 10,993 shares — an estimated $204K sold.

Walleye Capital first reported a position in CLB in Q3 2024 and held it in 1 quarter. The position peaked at $204K in Q3 2024. 209 funds tracked by Wall St. Rank hold CLB as of Q4 2024.

  • Walleye Capital reported no remaining Core Laboratories position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 10,993 Core Laboratories shares in Q4 2024, an estimated $204K.
  • Walleye Capital first reported a position in Core Laboratories in Q3 2024 and held it in 1 quarter.
  • Walleye Capital's Core Laboratories position peaked at $204K in Q3 2024.
  • 209 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.